Sequence optimized diagnostic assay for Ebola virus detection.

Area of Science:

• Molecular biology
• Virology
• Infectious disease diagnostics

Background:

• Rapid pathogen identification is crucial for outbreak control and patient management.
• Real-time PCR offers high sensitivity and specificity for infectious disease diagnosis.
• Primer/probe sequence mismatches can compromise assay performance, leading to false negatives.

Purpose of the Study:

• To assess the impact of sequence mismatches on Ebola virus (EBOV) real-time PCR assay performance.
• To evaluate the effectiveness of redesigned EBOV assays in detecting diverse viral variants.

Main Methods:

• Analysis of sequence variants in EBOV Makona from the 2013-2016 outbreak.
• In silico assessment of primer/probe mismatch impact on assay sensitivity.
• Redesign and validation of EBOV real-time PCR assays.
• Comparative performance testing of original and redesigned assays on human EBOV samples.

Main Results:

• One or two primer/probe mismatches caused sensitivity reductions from minimal to nearly two logs.
• Redesigned EBOV assays demonstrated improved detection across tested variants.
• New assays showed increased sensitivity, evidenced by lower Cq values and detection of previously missed positive samples.

Conclusions:

• EBOV genetic diversity can significantly impair real-time PCR diagnostic assay sensitivity.
• Assay redesign to account for sequence variants is essential for accurate EBOV detection.
• Improved EBOV assays enhance diagnostic capabilities for outbreak response and patient care.